GvHD Symposium

GvHD national symposium

Innovative And Life-Changing Research Presentations

The Meredith A. Cowden Foundation presented the 2017 National GvHD Health Symposium at the Grand Event Center in Columbus, OH on Friday, October 13th, 2017. This unique one-day conference consisted of two-tracks – one designed for physicians and other healthcare professionals and one for bone-marrow transplant (BMT) survivors, their families, and their caregivers. Both tracks focused on cutting-edge research and new treatments.

Last year, over 200 people attended this unique event providing an opportunity for survivors, their families, and caregivers to interact with some of the world’s leading authorities on the cause, treatment and management of Graft vs. Host Disease, a complication that affects over 60% of bone marrow transplant patients. It is the only program of its kind in the United States focusing on this very specific complication.

The 2017 Symposium
• Provided a scientifically rigorous and clinically applicable program to medical providers
• Provided programs for mid-level medical professionals and social workers who work with patients, survivors and their families
• Presented programs specifically to the interests of BMT survivors, their families, and their caregivers
• And, brought physicians and patients together to discuss issues, challenges, and successes of dealing with acute and chronic GvHD.

For more information, contact Lyn Haselton at lynhaselton@gmail.com

The Foundation would like to thank the Doctors and the other medical personnel
that gave their time and knowledge to make the 2017 National GvHD Symposium
a great success. We would also like to thank the more than 200 Doctors, medical
personnel, patients, caregivers and families that attended.

This was truly a day of learning for everyone who participated. THANK YOU!

2019 Symposium

Registration for the symposium is coming soon. Special hotel room pricing available via the link below.

2019 8th Annual Graft vs. Host Disease Symposium
Friday, April 26th 2019
Cleveland Airport Marriott
4277 West 150th Street
Cleveland OH 44135

Hotel Booking Info:
Cleveland Airport Marriot
(complimentary parking & basic internet)
Last day to book: 4/15/19
Special group rate: $85.00 per night

A Unique Conference

For Physicians, Health Care Professionals, And Survivors

This unique conference, which focuses on cutting edge research and new treatments, consists of two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.
Support The 2019 Symposium

Become a Sponsor

The following sponsorship opportunities are currently available.
Please contact Lyn Haselton, Event Coordinator, by emailing her at lynhaselton@gmail.com
if you have questions or are interested in other opportunities not listed.

$10,000 –Symposium Host Sponsor

• Logo recognition during the plenary session
• Company logo will appear in symposium syllabus
• Four complimentary meeting registrations

$7,500 – Speaker or Food/Beverage Sponsor

• Logo recognition during the plenary session
• Company logo will appear in symposium syllabus
• Three complimentary meeting registrations

$5,000 – Plenary Session Sponsor

• Logo recognition during the plenary session
• Company name recognition in symposium syllabus
• Two complimentary meeting registrations

$2,500 – Patient Scholarship Sponsor

• Logo recognition during the plenary session
• Company name recognition in symposium syllabus
• One complimentary meeting registration

$2,000 – Symposium Video Sponsor

• Receive logo recognition at beginning and end of the video. The video will be used for patient education and information only and will be available through the Meredith A. Cowden Foundation website and other BMT patient service organizations.
• One complimentary meeting registration

$1,500 – Exhibit Tables

Symposium Speakers

GvHD Symposium Speakers - Past
Jeffery J. Auletta, MD
Assistant Professor
Pediatric Hematology Oncology
University Hospitals Case Medical Center
Case Western Reserve University

Kenneth R. Cooke, MD
Ohio Eminent Scholar and Leonard P. Hannah Professor in Stem Cell and Regenerative Medicine
National Center for Regenerative Medicine
Case Western Reserve University
Director, Pediatric BMT Program and The Multidisciplinary Initiative in GVHD
University Hospitals Case Medical Center

Ellen R. Frank, PhD
Bone Marrow Transplant Survivor
Senior Chair, Dana-Farber Patient
Advisory Council

Angie Giallourakis, PhD
Adjunct Faculty, Special Education
Cleveland State University

Stanton L. Gerson, MD
Professor of Hematological Oncology
Director, NCI-designated Case Comprehensive Cancer Center
Director, National Center for Regenerative Medicine (NCRM)
Case Western Reserve University Director, Ireland Cancer Center
University Hospitals Case Medical Center

Mary Guay, PA
Physician Assistant
Hillman Cancer Center

Matt E. Kalaycio, MD, FACP
Professor, Cleveland Clinic Lerner College of Medicine at CWRU
Staff, Hematologic Oncology and Blood Disorders Taussig Cancer Institute, Cleveland Clinic

Mandy C. Leonard, BS, PharmD,BCPS
Assistant Professor, Cleveland Clinic
Lerner College of Medicine at CWRU
Assistant Director, Drug Information Service, Cleveland Clinic

George B. McDonald, MD
Professor of Medicine
University of Washington School of Medicine
Head, Gastroenterology/Hepatology Section
Fred Hutchinson Cancer Research Center

Christy Paddon, LMSW
Medical Social Worker
Blood and Marrow Transplant Program
Roswell Park Cancer Institute

Steven Z. Pavletic, MD, MS
Experimental Transplantation and
Immunology Branch Staff Clinician
National Cancer Institute

Pavan Reddy, MD
Associate Professor
Department of Internal Medicine
University of Michigan

Sue Stewart
Founder and CEO, Blood and Marrow
Transplant Information Network

Marcel R.M. van den Brink, MD, PhD
Professor of Medicine and Immunology
Weill Medical College, Cornell University
Head, Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center

Daniel J. Weisdorf, MD
Professor, Department of Medicine
Masonic Cancer Center
University of Minnesota
Scientific Director, National Marrow Donor Program

Catherine Bollard, MBChB, MD
Associate Professor of Pediatrics,
Medicine and Immunology
Baylor College of Medicine
Center for Cell and Gene Therapy

Ryan N. Bookout, PharmD, BCOP
Department of Blood and Marrow Transplantation
H. Lee Moffi tt Cancer Center and Research Institute

Anthony G. Brickner, PhD
Assistant Professor of Medicine
Immunology and Clinical and Translational Science
University of Pittsburgh Cancer Institute

Paul Carpenter, MBBS
Associate Professor
Department of Pediatrics
Fred Hutchinson Cancer Research Center

Stanton L. Gerson, MD
Professor of Medicine
Division of Hematology and Oncology
Director, Case Comprehensive Cancer Center
Case Western Reserve University SOM
Director, Seidman Cancer Center
University Hospitals Case Medical Center

Flora Hoodin, PhD
Professor, Department of Psychology
Eastern Michigan University
Adjunct Clinical Associate Professor
Department of Psychiatry
University of Michigan

Hillard M. Lazarus, MD
Professor of Medicine
Division of Hematology and Oncology
Case Western Reserve University SOM
Chair, Cancer IRB
University Hospitals Case Medical Center

Lindsay Maurath, MS
Outpatient Dietitian
Cleveland Clinic

Robert S. Negrin, MD
Professor of Medicine
Medical Director, Clinical Bone Marrow Transplantation Laboratory
Division Chief, Blood and Marrow Transplantation Program
Stanford University

Joseph C. Noreika, MD
Excellence in Eyecare Inc., Medina, OH
Consulting Staff
Summa Wadsworth-Rittman Hospital

Sophie Paczesny, MD, PhD
Assistant Professor, Pediatrics and Communicable Diseases
Blood and Marrow Transplant Program
University of Michigan

Gerard Socie, MD, PhD
Professor and Head, Hematology / Transplantation
Hospital Saint Louis, Paris, France

Robert J. Soiffer, MD
Chief, Division of Hematologic Malignancies
Co-Chief, Stem Cell/Bone Marrow Transplantation Program
Dana-Farber Cancer Institute

Claudio Anasetti, MD
Professor and Chair
Department of Blood & Marrow Transplant
H. Lee Moffi tt Cancer Center & Research Institute

Kenneth R. Cooke, MD Ohio Eminent
Scholar and Leonard C. Hanna Professor in Stem Cell and Regenerative Medicine
Case Western Reserve University
Director, Pediatric Blood and Marrow Transplantation Program
Director, Multidisciplinary Initiative in Graft-vs-Host Disease
University Hospitals Case Medical Center

Corey S. Cutler, MD, MPH, FRCPC
Assistant Professor
Department of Medicine
Harvard Medical School
Dana-Farber Cancer Institute

Tanya Edwards, MD
Cleveland Clinic

Matt Kalaycio, MD, FACP
Professor, Cleveland Clinic Lerner
College of Medicine of Case Western Reserve University
Director, Bone Marrow Transplant Program
Taussig Cancer Institute, Cleveland Clinic

Stanton L. Gerson, MD
Professor of Medicine
Division of Hematology and Oncology
Director, Case Comprehensive Cancer Center
Case Western Reserve University SOM
Director, Seidman Cancer Center
University Hospitals Case Medical Center

Sandra Mitchell, PhD, CRNP
Research Scientist, Outcomes Research
Branch Nurse Practitioner
NCI Chronic Graft-Versus-Host-Disease Clinic and Study Group

William J. Murphy, PhD
Professor and Vice Chair
Department of Dermatology
University of California – Davis

Steven Pavletic, MD, MS
Experimental Transplantation and
Immunology Branch
National Cancer Institute

Effie Petersdorf, MD
Professor, Department of Medicine
University of Washington
Attending Physician
Seattle Cancer Care Alliance

Stefanie Sarantopoulos, MD, PhD
Assistant Professor
Department of Medicine
Division of Hematology/Oncology
University of North Carolina

Warren D. Shlomchik, MD
Associate Professor
Department of Medicine
Smilow Cancer Hospital
Yale School of Medicine

Keren Stronach, MPH
Health Care Navigator
UCSF Comprehensive Cancer Center

Keith M. Sullivan, MD
Department of Medicine
Division of Cellular Therapy
Duke University Medical Center

2016, 2017, 2018

GvHD Symposium Sponsors

Case Comprehensive Cancer Center
The Case Comprehensive Cancer Center (Case CCC) based at Case Western Reserve University (CWRU) is a partnership organization supporting all cancer-related research efforts at CWRU, University Hospitals Case Medical Center, and the Cleveland Clinic. Located in Cleveland, Ohio, the Case CCC serves the cancer research and clinical needs of an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio
University Hospitals Seidman Cancer Center
University Hospitals Seidman Cancer Center, part of the Case Comprehensive Cancer Center, is dedicated to the innovative treatment and promising research in the fight against cancer through ongoing studies aimed at cancer treatment and prevention.

One of only 41 Comprehensive Cancer Centers in the country designated by the National Cancer Institute (NCI), Seidman can offer cutting-edge treatments earlier than most other cancer centers. Our affiliation with Case Western Reserve University provides ongoing studies aimed at cancer treatment and prevention.

Patients receive skilled care through our multidisciplinary team approach. Experts in surgery, medical oncology, radiation therapy, pathology, nursing, social work, and psychology work together to create a personalized treatment plan that meets physical, emotional and spiritual needs.

Recognized by U.S. News and World Report as one of the top hospitals for cancer care in the country, the mission of Seidman Cancer Center is simple: to cure cancer

Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute provides world-class care to patients with cancer and is at the forefront of new and emerging clinical, translational and basic cancer research.

Cleveland Clinic is moving toward the forefront of the cancer drug discovery revolution and cancer research. Through cancer research, we have identified new molecules with anti-tumor effects, developed collaborative ties with biotechnology companies, begun training more young scientists and expanded our base of financial support. These bold steps in cancer research will result in discovery and application of new therapies to help us eliminate cancer as a significant cause of mortality.

Other Sponsors

Acknowledgments

Grants Provided by
Incyte Pharmaceuticals
Mallinckrodt Pharmaceuticals

Exhibits Provided by
AbbVie
Amgen
Avadim Technologies, Inc.
Celgene Corportation
Jazz Pharmaceuticals
Pfizer, Inc.
Pharmacyclics LLC and Janssen Biotech, Inc.
Seattle Genetics

Other Support Provided by
Pharmacyclics LLC and Janssen Biotech, Inc.
Acceptance of funding in support of this program does not constitute the endorsement of any product or manufacturer.

Patient Resource Exhibitors
BMTInfoNet
Leukemia & Lymphoma Society
Meredith A. Cowden Foundation
National Marrow Donor Program
nbmtLink

Pin It on Pinterest